−28.16 MEUR
19.19 M
About VIVORYON THERAPEUTICS
Sector
Industry
CEO
Frank T. Weber
Website
Headquarters
Halle
Employees (FY)
17
Founded
2001
ISIN
NL00150002Q7
FIGI
BBG007BB73Q5
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange VIVORYON THERAPEUTICS stocks are traded under the ticker 05Y.
VIVORYON THERAPEUTICS is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for VIVORYON THERAPEUTICS has a max estimate of 64.000 EUR and a min estimate of 0.700 EUR.
Yes, you can track VIVORYON THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
No, 05Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 05Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVORYON THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 17.00 employees. See our rating of the largest employees — is VIVORYON THERAPEUTICS on this list?
We've gathered analysts' opinions on VIVORYON THERAPEUTICS future price: according to them, 05Y price has a max estimate of 64.00 EUR and a min estimate of 0.70 EUR. Read a more detailed VIVORYON THERAPEUTICS forecast: see what analysts think of VIVORYON THERAPEUTICS and suggest that you do with its stocks.